rs61754178

Positions:

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_003183.6(ADAM17):ā€‹c.148A>Gā€‹(p.Ile50Val) variant causes a missense change. The variant allele was found at a frequency of 0.00455 in 1,610,016 control chromosomes in the GnomAD database, including 25 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā˜…ā˜…).

Frequency

Genomes: š‘“ 0.0042 ( 1 hom., cov: 33)
Exomes š‘“: 0.0046 ( 24 hom. )

Consequence

ADAM17
NM_003183.6 missense

Scores

7
12

Clinical Significance

Likely benign criteria provided, multiple submitters, no conflicts B:7

Conservation

PhyloP100: 5.44
Variant links:
Genes affected
ADAM17 (HGNC:195): (ADAM metallopeptidase domain 17) This gene encodes a member of the ADAM (a disintegrin and metalloprotease domain) family. Members of this family are membrane-anchored proteins structurally related to snake venom disintegrins, and have been implicated in a variety of biologic processes involving cell-cell and cell-matrix interactions, including fertilization, muscle development, and neurogenesis. The encoded preproprotein is proteolytically processed to generate the mature protease. The encoded protease functions in the ectodomain shedding of tumor necrosis factor-alpha, in which soluble tumor necrosis factor-alpha is released from the membrane-bound precursor. This protease also functions in the processing of numerous other substrates, including cell adhesion proteins, cytokine and growth factor receptors and epidermal growth factor (EGF) receptor ligands, and plays a prominent role in the activation of the Notch signaling pathway. Elevated expression of this gene has been observed in specific cell types derived from psoriasis, rheumatoid arthritis, multiple sclerosis and Crohn's disease patients, suggesting that the encoded protein may play a role in autoimmune disease. Additionally, this protease may play a role in viral infection through its cleavage of ACE2, the cellular receptor for SARS-CoV and SARS-CoV-2. [provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0067513883).
BP6
Variant 2-9543235-T-C is Benign according to our data. Variant chr2-9543235-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 472722.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr2-9543235-T-C is described in Lovd as [Likely_benign].
BS1
Variant frequency is greater than expected in population amr. gnomad4 allele frequency = 0.0042 (639/152266) while in subpopulation AMR AF= 0.00752 (115/15284). AF 95% confidence interval is 0.00641. There are 1 homozygotes in gnomad4. There are 315 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAdExome4 at 24 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
ADAM17NM_003183.6 linkuse as main transcriptc.148A>G p.Ile50Val missense_variant 2/19 ENST00000310823.8 NP_003174.3
ADAM17XM_047445610.1 linkuse as main transcriptc.55A>G p.Ile19Val missense_variant 3/20 XP_047301566.1
ADAM17NM_001382777.1 linkuse as main transcriptc.-533A>G 5_prime_UTR_variant 2/19 NP_001369706.1
ADAM17NM_001382778.1 linkuse as main transcriptc.-775A>G 5_prime_UTR_variant 2/19 NP_001369707.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
ADAM17ENST00000310823.8 linkuse as main transcriptc.148A>G p.Ile50Val missense_variant 2/191 NM_003183.6 ENSP00000309968 P1P78536-1

Frequencies

GnomAD3 genomes
AF:
0.00421
AC:
641
AN:
152148
Hom.:
1
Cov.:
33
show subpopulations
Gnomad AFR
AF:
0.00104
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.00760
Gnomad ASJ
AF:
0.00173
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000621
Gnomad FIN
AF:
0.00358
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00595
Gnomad OTH
AF:
0.00812
GnomAD3 exomes
AF:
0.00376
AC:
932
AN:
248098
Hom.:
5
AF XY:
0.00384
AC XY:
515
AN XY:
134124
show subpopulations
Gnomad AFR exome
AF:
0.000620
Gnomad AMR exome
AF:
0.00493
Gnomad ASJ exome
AF:
0.000900
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000771
Gnomad FIN exome
AF:
0.00372
Gnomad NFE exome
AF:
0.00554
Gnomad OTH exome
AF:
0.00315
GnomAD4 exome
AF:
0.00459
AC:
6687
AN:
1457750
Hom.:
24
Cov.:
30
AF XY:
0.00449
AC XY:
3257
AN XY:
725242
show subpopulations
Gnomad4 AFR exome
AF:
0.000631
Gnomad4 AMR exome
AF:
0.00482
Gnomad4 ASJ exome
AF:
0.00111
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000947
Gnomad4 FIN exome
AF:
0.00389
Gnomad4 NFE exome
AF:
0.00533
Gnomad4 OTH exome
AF:
0.00355
GnomAD4 genome
AF:
0.00420
AC:
639
AN:
152266
Hom.:
1
Cov.:
33
AF XY:
0.00423
AC XY:
315
AN XY:
74460
show subpopulations
Gnomad4 AFR
AF:
0.00103
Gnomad4 AMR
AF:
0.00752
Gnomad4 ASJ
AF:
0.00173
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000622
Gnomad4 FIN
AF:
0.00358
Gnomad4 NFE
AF:
0.00594
Gnomad4 OTH
AF:
0.00803
Alfa
AF:
0.00480
Hom.:
6
Bravo
AF:
0.00412
TwinsUK
AF:
0.00405
AC:
15
ALSPAC
AF:
0.00519
AC:
20
ESP6500AA
AF:
0.000681
AC:
3
ESP6500EA
AF:
0.00419
AC:
36
ExAC
AF:
0.00368
AC:
447

ClinVar

Significance: Likely benign
Submissions summary: Benign:7
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:5
Likely benign, no assertion criteria providedclinical testingGenome Diagnostics Laboratory, University Medical Center Utrecht-- -
Likely benign, criteria provided, single submitterclinical testingCeGaT Center for Human Genetics TuebingenJul 01, 2024ADAM17: BS2 -
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Likely benign, no assertion criteria providedclinical testingDiagnostic Laboratory, Department of Genetics, University Medical Center Groningen-- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
ADAM17-related disorder Benign:1
Likely benign, no assertion criteria providedclinical testingPreventionGenetics, part of Exact SciencesOct 14, 2019This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -
Inflammatory skin and bowel disease, neonatal, 1 Benign:1
Likely benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 29, 2024- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.48
T
BayesDel_noAF
Benign
-0.45
CADD
Benign
19
DANN
Uncertain
1.0
DEOGEN2
Benign
0.051
T;T;.
Eigen
Uncertain
0.32
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.93
D
LIST_S2
Uncertain
0.94
.;D;D
M_CAP
Benign
0.0042
T
MetaRNN
Benign
0.0068
T;T;T
MetaSVM
Benign
-1.0
T
MutationAssessor
Uncertain
2.1
M;M;.
MutationTaster
Benign
0.77
D;D
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-0.57
N;N;.
REVEL
Benign
0.11
Sift
Benign
0.30
T;T;.
Sift4G
Benign
0.12
T;T;.
Polyphen
0.62
P;P;.
Vest4
0.49
MVP
0.45
MPC
0.59
ClinPred
0.034
T
GERP RS
5.3
Varity_R
0.14
gMVP
0.39

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.020
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs61754178; hg19: chr2-9683364; COSMIC: COSV99072205; API